POMT2 gene mutation in limb-girdle muscular dystrophy with inflammatory changes

Biochemical and Biophysical Research Communications

Volumn 363, Issue 4, 2007, Pages 1033-1037

  Biancheri, Roberta ^a   Falace, Antonio ^a   Tessa, Alessandra ^b   Pedemonte, Marina ^a   Scapolan, Sara ^a   Cassandrini, Denise ^a   Aiello, Chiara ^b   Rossi, Andrea ^c   Broda, Paolo ^a   Zara, Federico ^a   Santorelli, Filippo Maria ^b   Minetti, Carlo ^a   Bruno, Claudio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c G GASLINI INSTITUTE   (Italy)

Author keywords

Congenital muscular dystrophy; Dystroglycan; Glycosylation; POMT2

Indexed keywords

ALPHA DYSTROGLYCAN; MANNOSYLTRANSFERASE; PROTEIN O MANNOSYL TRANSFERASE 1; PROTEIN O MANNOSYL TRANSFERASE 2; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GENE IDENTIFICATION; GENE MUTATION; GUILLAIN BARRE SYNDROME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIMB GIRDLE MUSCULAR DYSTROPHY; MUSCLE BIOPSY; MUSCULAR DYSTROPHY; PRIORITY JOURNAL;

BASE SEQUENCE; BIOPSY; CHILD, PRESCHOOL; FEMALE; HUMANS; INFLAMMATION; MANNOSYLTRANSFERASES; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; MUTATION;

EID: 35148838187     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.09.066     Document Type: Article

References (22)

1. Muntoni F., and Voit T. The congenital muscular dystrophies in 2004: a century of exciting progress. Neuromuscul. Disord. 14 (2004) 635-649
2. Henry M.D., and Campbell K.P. Dystroglycan inside and out. Curr. Opin. Cell Biol. 11 (1999) 602-607
3. Michele D.E., and Campbell K.P. Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function. J. Biol. Chem. 278 (2003) 15457-15460
4. Willer T., Amselgruber W., Deutzmann R., and Strahl S. Characterization of POMT2, a novel member of the PMT protein O-mannosyltransferase family specifically localized to the acrosome of mammalian spermatids. Glycobiology 12 (2002) 771-783
5. van Reeuwijk J., Janssen M., van den Elzen C., et al. POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome. J. Med. Genet. 42 (2005) 907-912
6. Mercuri E., D'Amico A., Tessa A., et al. POMT2 mutation in a patient with 'MEB-like' phenotype. Neuromuscul. Disord. 16 (2006) 446-448
7. Yanagisawa A., Bouchet C., Van der Bergh P.Y., et al. New POMT2 mutations causing congenital muscular dystrophy. Neurology (2007) Jul. 18 [Epub ahead of print]
8. Bouchet C., Gonzales M., Vuillaumier-Barrot S., et al. Molecular heterogeneity in fetal forms of type II lissencephaly. Hum. Mutat. (2007) Jun. 8; [Epub ahead of print]
9. Brockington M., Blake D.J., Prandini P., et al. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am. J. Hum. Genet. 69 (2001) 1198-1209
10. Brockington M., Yuva Y., Prandini P., et al. Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum. Mol. Genet. 10 (2001) 2851-2859
11. Topaloglu H., Brockington M., Yuva Y., et al. FKRP gene mutations cause congenital muscular dystrophy, mental retardation, and cerebellar cysts. Neurology 60 (2003) 988-992
12. Mercuri E., Topaloglu H., Brockington M., et al. Spectrum of brain changes in patients with congenital muscular dystrophy and FKRP gene mutations. Arch. Neurol. 63 (2006) 251-257
13. Beltran-Valero de Bernabe D., Currier S., Steinbrecher A., et al. Mutations in the O-mannosyl-transferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am. J. Hum. Genet. 71 (2002) 1033-1043
14. Balci B., Uyanik G., Dincer P., et al. An autosomal recessive limb girdle muscular dystrophy (LGMD2) with mild mental retardation is allelic to Walker-Warburg syndrome (WWS) caused by a mutation in the POMT1 gene. Neuromuscul. Disord. 15 (2005) 271-275
15. D'Amico A., Tessa A., Bruno C., et al. Expanding the clinical spectrum of POMT1 phenotype. Neurology 66 (2006) 1564-1567
16. van Reeuwijk J., Grewal P.K., Salih M.A., et al. Intragenic deletion in the LARGE gene causes Walker-Warburg syndrome. Hum. Genet. 121 (2007) 685-690
17. Biancheri R., Bertini E., Falace A., et al. POMGnT1 mutations in congenital muscular dystrophy: genotype-phenotype correlation and expanded clinical spectrum. Arch. Neurol. 63 (2006) 1491-1495
18. Lehle L., Strahl S., and Tanner W. Protein glycosylation, conserved from yeast to man: a model organism helps elucidate congenital human diseases. Angew Chem. Int. Ed. Engl. 45 1 (2006) 6802-6818
19. Krahn M., Lopez de Munain A., Streichenberger N., et al. CAPN3 mutations in patients with idiopathic eosinophilic myositis. Ann. Neurol. 59 (2006) 905-911
20. Brown R.H., and Amato A. Calpainopathy and eosinophilic myositis. Ann. Neurol. 59 (2006) 875-877
21. Pegoraro E., Mancias P., Swerdlow S.H., et al. Congenital muscular dystrophy with primary laminin alpha2 (merosin) deficiency presenting as inflammatory myopathy. Ann. Neurol. 40 5 (1996) 782-791
22. Godfrey C., Escolar D., Brockington M., et al. Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophy. Ann. Neurol. 60 (2006) 603-610